Since IL-17 producing T cells are present within atrophic lesions and in the subretinal space of eye sections obtained from GA patients [30], this suggests that DMF may also be beneficial to treat patients suffering from the dry form of AMD by inhibiting their activation [104]. This evidence concerns the gene IL17A and age-related macular degeneration.